NanoGuardian makes board appointment
This article was originally published in Scrip
NanoGuardian (US), a division of NanoInk, has appointed Dr John Glover to lead its security advisory board. He has a career spanning more than 35 years with the FBI, Bristol-Myers Squibb, the Pharmaceutical Security Institute and the US State Department. Dr Glover will advise NanoGuardian in its efforts to curb the spread of counterfeit and diverted pharmaceuticals in the supply chain.
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
Series C investment of an undisclosed amount announced in early May follows $20m funding for the Los Angeles company from Volition Capital and angel investors.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.